TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Investing
3 Reasons I Love This Trifecta of Growth

Cannabis Stocks
Canopy Growth Corp (TSX:WEED) at $55: Should Investors Buy the Dip?

Cannabis Stocks
Marijuana Investors: Have You Considered This Major Risk?

Cannabis Stocks
Investor Alert: Cronos Group Inc. (TSX:CRON) Reports Slower Revenue Growth and a Bigger-Than-Expected Loss

Tech Stocks
Forget Canopy and Aurora: These 3 Stocks Are Positioned to Gobble Up Marijuana Profits

Investing
Better Buy in April: Aurora Cannabis Inc. (TSX:ACB) or Canopy Growth Corp. (TSX:WEED)?

Energy Stocks
Will Marijuana Replace Oil As Canada’s National Treasure?

Cannabis Stocks
Canopy Growth (TSX:WEED) Increases U.S. Investment: Is This Accretive to Growth?

Cannabis Stocks
Canopy Growth Corp (TSX:WEED) Makes Another Move in the U.S. Hemp Market

Cannabis Stocks
3 Reasons to Be Wary of Canopy Growth Corp (TSX:WEED) and Cannabis Stocks in General

Cannabis Stocks
3 Marijuana Stocks That Beat Canopy Growth Corp (TSX:WEED) to Profitability
